Trials / Withdrawn
WithdrawnNCT00451490
The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Phase advance of HRV will be anticipated in agomelatine group. It is anticipated that both agomelatine and floxentine will increase HRV at the end of the treatment.
Detailed description
Phase advance of HRV will be anticipated in agomelatine group. It is anticipated that both agomelatine and floxentine will have equal efficacy in improvement of depressive symptoms and increasement of HRV at the end of the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Agomelatine | |
| DRUG | Fluoxentine |
Timeline
- Start date
- 2006-10-01
- Completion
- 2007-12-01
- First posted
- 2007-03-23
- Last updated
- 2008-01-08
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00451490. Inclusion in this directory is not an endorsement.